Fatty liver disease (MASLD/MASH): open trials in Singapore

8 open trials have a site in Singapore. Registry data; only the trial team decides who can take part.

NCT06632444
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
Changi General Hospital, Singapore · National University Hospital, Singapore · Singapore General Hospital, Singapore
Registry updated 2026-10-28
NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Trial Treatment · Phase 3 · Boehringer Ingelheim
National University Hospital, Singapore · Changi General Hospital, Singapore · Singapore General Hospital, Singapore
Registry updated 2026-10-28
NCT07285135
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
Trial Treatment · Singapore General Hospital
Singapore General Hospital, Singapore
Registry updated 2026-10-27
NCT06318169
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Singapore
Registry updated 2026-10-23
NCT06419374
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Trial Treatment · Phase 3 · Hoffmann-La Roche
Singapore
Registry updated 2026-10-23
NCT07861191
RESET-INSPIRE Study: Insulin Sensitivity & Population Intervention With Real-time Evaluation Using CGM
Research · National University Health System, Singapore
MD6, Centre for Translational Medicine, 14 Medical Drive, Singapore 117599, Singapore
Registry updated 2026-10-06
NCT06890169
OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related Comorbidities
Trial Treatment · Changi General Hospital
Changi General Hospital, Singapore
Registry updated 2025-03-21
NCT06211868
Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
Research · National University Hospital, Singapore
NUS, Singapore
Registry updated 2024-10-15

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error